Pharmaceutical / Drug Definition :
Undergoes conversion to free thiol, an active metabolite that reduces toxic effects of cisplatin on renal tissue
Registrar Corp assists Amifostine companies with:
FDA Registration
Amifostine
FDA Listing
Amifostine
FDA Label Requirements and Exceptions
Amifostine
FDA Import Information
Amifostine
FDA Detentions
Amifostine (Amifostine Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Amifostine (Amifostine Suppliers)
- Processors Amifostine
- Repackers Amifostine
- Relabelers Amifostine
- Exporters Amifostine
- Importers Amifostine
For more information about Amifostine, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
